Invasive fungal infections in patients receiving intensive cytotoxic therapy for cancer.
Bow
E J
EJ
Department of Internal Medicine and Medical Microbiology, the University of Manitoba, and the Manitoba Cancer Treatment and Research Foundation, Winnipeg, Canada.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D009181:Mycoses / Q000150:complications*; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D009894:Opportunistic Infections / Q000150:complications*; D012307:Risk Factors
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents